Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study (Q59814220)
Jump to navigation
Jump to search
scientific article published in December 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study |
scientific article published in December 2007 |
Statements
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study (English)
Elisabetta Mandosi
Claudio Tiberti
Mara Fallarino
Barbara Buchetti
Alessandra Gatti
Maurizio Sensi
25 April 2007